Skip to main content
Livermore
Livermore
ZHEN

Dimensional Fund Advisors LP

SEC CIK
0000354204
Latest filing
Aug 11, 2026

ALDX holding history

Aldeyra Therapeutics, Inc. in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALDX overviewAll 13F holders of ALDXFull Q2 2026 holdings

Shares (Q2 2026)
529,083
Value
$1.13M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ALDX by Dimensional Fund Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026529,083$1.13M<0.1%−95,087−15.2%ReducedHolders
Q1 2026624,170$1.05M<0.1%+11,912+1.9%AddedHolders
Q4 2025612,258$3.17M<0.1%−36,113−5.6%ReducedHolders
Q3 2025648,371$3.38M<0.1%−70,342−9.8%ReducedHolders
Q2 2025718,713$2.75M<0.1%+48,863+7.3%AddedHolders
Q1 2025669,850$3.85M<0.1%−65,913−9.0%ReducedHolders
Q4 2024735,763$3.67M<0.1%+131,722+21.8%AddedHolders
Q3 2024604,041$3.26M<0.1%−68,016−10.1%ReducedHolders
Q2 2024672,057$2.22M<0.1%−210,153−23.8%ReducedHolders
Q1 2024882,210$2.88M<0.1%−156,442−15.1%ReducedHolders
Q4 20231,038,652$3.65M<0.1%−166,372−13.8%ReducedHolders
Q3 20231,205,024$8.05M<0.1%+79,379+7.1%AddedHolders
Q2 20231,125,645$9.44M<0.1%+2,737+0.2%AddedHolders
Q1 20231,122,908$11.1M<0.1%+232,676+26.1%AddedHolders
Q4 2022890,232$6.20M<0.1%+210,219+30.9%AddedHolders
Q3 2022680,013$3.63M<0.1%+597,093+720.1%AddedHolders
Q2 202282,920$331.0K<0.1%−84,699−50.5%ReducedHolders
Q1 2022167,619$745.0K<0.1%−91,999−35.4%ReducedHolders
Q4 2021259,618$1.04M<0.1%−11,766−4.3%ReducedHolders
Q3 2021271,384$2.38M<0.1%00.0%UnchangedHolders
Q2 2021271,384$3.08M<0.1%−3,451−1.3%ReducedHolders
Q1 2021274,835$3.27M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.